Follow

ZINZINO AB (PUBL): PRELIMINARY SALES REPORT JANUARY 2023

03 February 2023 - 11:00

Zinzino group revenue increased with a total of 18%, compared with the previous year.

The revenue in January for Zinzino's sales markets increased by 18% and amounted to SEK 120.0 (102.1) million. Faun Pharma's external sales increased by 32% and amounted to SEK 9.1 (6.9) million. Overall, the Group increased revenues by 18% to SEK 129.1 (109.0) million compared with the previous year.

Revenues were distributed as follows:

Regions, mSEK 23-Jan 22-Jan Change
The Nordics 23,1 26,0 -11%
Central Europe 28,5 18,4 55%
East Europe 32,8 28,6 15%
South & West Europe 15,9 12,1 31%
The Baltics 7,4 6,5 14%
North America 6,3 4,4 43%
Asia-Pacific 4,6 5,7 -19%
Africa 1,4 0,4 250%
Zinzino 120,0 102,1 18%
Faun Pharma 9,1 6,9 32%
Zinzino Group 129,1 109,0 18%

Countries in regions:

-The Nordics: Denmark, Faroe Island, Finland, Iceland, Norway, Sweden
-Central Europe: Austria, Germany, Switzerland
-East Europe: Czech Republic, Slovakia, Hungary, Poland, Romania
-South & West Europe: Cyprus, France, Greece, Italy, Luxembourg, Malta, Netherlands, Slovenia, Spain, United Kingdom, Belgium, Ireland
-The Baltics: Estonia, Latvia, Lithuania
-North America: Canada, USA
-Asia-Pacific: Australia, Hong Kong, India, Malaysia, Singapore, Taiwan, Thailand
-Africa: South Africa

For more information:
Dag Bergheim Pettersen CEO Zinzino +47 (0) 932 25 700, zinzino.com

Pictures for publication free of charge:
[email protected]

Certified Adviser: Erik Penser Bank Aktiebolag, +46 (0) 8 463 83 00, email: [email protected]


Zinzino AB (publ) is obliged to publish this information in compliance with current EU regulations governing market abuse. The information was provided by the above contact person for publication at 11:00 the 3rd of February 2023.

Zinzino is a global direct sales company from Scandinavia specializing in test-based, personalized nutrition and scientific skincare. It is a public limited company with its shares listed on Nasdaq First North Premier Growth Market. Their scientifically proven nutritional supplements are available on more than 100 markets across the world. Zinzino owns the Swiss, biotech skincare brand HANZZ+HEIDII, as well as the Norwegian research and production units BioActive Foods AS and Faun Pharma AS. The company headquarters is in Gothenburg, Sweden with additional offices in Europe, Asia, the US and Australia.

Provided by: Cision
Nasdaq First North GM Stockholm (Sweden)
Zinzino Holding AB
Zinzino is a direct sales company which offers products focusing on nutritional supplements, skincare, and lifestyle products. The Company operates in three segments Zinzino; Faun and VMA Life....
Learn more about company

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More